Veritas In Silico Inc. 130AShort Interest
Estimated short interest in Veritas In Silico Inc. (130A) is 2.51% of shares outstanding as of 2026-07-29. No institution currently holds 0.5% or more.
Estimated short interest
2.51%
▼0.08%
Estimated position (shares)
164,600
As of 2026-07-29
Holders (0.5% or more)
0 firms
287 reports
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest, stacking the latest reported position of each short seller. The 5 largest current holders are shown in color and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- UBS AG
- MERRILL LYNCH INTERNATIONAL
- Morgan Stanley MUFG Securities Co., Ltd.
- Barclays Capital Securities Ltd
- Integrated Core Strategies (Asia) Pte. Ltd.
- Others
2.51%
Estimated short interest, 2026-07-29
Others0.36%
Integrated Core Strategies (Asia) Pte. Ltd.0.39%
Barclays Capital Securities Ltd0.42%
Morgan Stanley MUFG Securities Co., Ltd.0.43%
MERRILL LYNCH INTERNATIONAL0.44%
UBS AG0.47%
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-01-28 | UBS AG | Position 30,500 shares | Ratio 0.47% | ▼0.03% | Below 0.5% |
| 2026-04-15 | MERRILL LYNCH INTERNATIONAL | Position 29,100 shares | Ratio 0.44% | ▼0.07% | Below 0.5% |
| 2026-07-29 | Morgan Stanley MUFG Securities Co., Ltd. | Position 28,300 shares | Ratio 0.43% | ▼0.08% | Below 0.5% |
| 2026-06-19 | Barclays Capital Securities Ltd | Position 27,300 shares | Ratio 0.42% | ▼0.17% | Below 0.5% |
| 2024-10-22 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 25,600 shares | Ratio 0.39% | ▼0.18% | Below 0.5% |
| 2025-08-05 | Nomura International plc | Position 23,800 shares | Ratio 0.36% | ▼0.35% | Below 0.5% |
Disclosure History 287 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-07-29 | Morgan Stanley MUFG Securities Co., Ltd. | Position 28,300 shares | Ratio 0.43% | ▼0.08% | Below 0.5% |
| 2026-06-19 | Barclays Capital Securities Ltd | Position 27,300 shares | Ratio 0.42% | ▼0.17% | Below 0.5% |
| 2026-06-15 | Morgan Stanley MUFG Securities Co., Ltd. | Position 33,300 shares | Ratio 0.51% | ▲0.11% | — |
| 2026-06-11 | Barclays Capital Securities Ltd | Position 38,900 shares | Ratio 0.59% | ▼0.10% | — |
| 2026-06-04 | Barclays Capital Securities Ltd | Position 45,300 shares | Ratio 0.69% | ▲0.09% | — |
| 2026-06-03 | Barclays Capital Securities Ltd | Position 45,700 shares | Ratio 0.70% | ▲0.10% | — |
| 2026-05-29 | Barclays Capital Securities Ltd | Position 39,400 shares | Ratio 0.60% | ▲0.07% | — |
| 2026-05-22 | Morgan Stanley MUFG Securities Co., Ltd. | Position 31,100 shares | Ratio 0.47% | ▼0.12% | Below 0.5% |
| 2026-05-20 | Morgan Stanley MUFG Securities Co., Ltd. | Position 38,800 shares | Ratio 0.59% | ▼0.08% | — |
| 2026-05-19 | Morgan Stanley MUFG Securities Co., Ltd. | Position 43,500 shares | Ratio 0.67% | ▼0.12% | — |
| 2026-05-14 | Barclays Capital Securities Ltd | Position 34,800 shares | Ratio 0.53% | ▲0.07% | — |
| 2026-05-01 | Barclays Capital Securities Ltd | Position 30,200 shares | Ratio 0.46% | ▼0.07% | Below 0.5% |
| 2026-04-30 | Barclays Capital Securities Ltd | Position 35,000 shares | Ratio 0.53% | ▲0.04% | — |
| 2026-04-28 | Barclays Capital Securities Ltd | Position 32,400 shares | Ratio 0.49% | ▼0.12% | Below 0.5% |
| 2026-04-21 | Barclays Capital Securities Ltd | Position 39,600 shares | Ratio 0.61% | ▲0.07% | — |
| 2026-04-16 | Barclays Capital Securities Ltd | Position 35,200 shares | Ratio 0.54% | ▲0.05% | — |
| 2026-04-15 | MERRILL LYNCH INTERNATIONAL | Position 29,100 shares | Ratio 0.44% | ▼0.07% | Below 0.5% |
| 2026-04-15 | Barclays Capital Securities Ltd | Position 32,200 shares | Ratio 0.49% | ▼0.05% | Below 0.5% |
| 2026-04-14 | MERRILL LYNCH INTERNATIONAL | Position 33,100 shares | Ratio 0.51% | ▼0.12% | — |
| 2026-04-13 | MERRILL LYNCH INTERNATIONAL | Position 41,100 shares | Ratio 0.63% | ▼0.16% | — |
| 2026-04-13 | Barclays Capital Securities Ltd | Position 35,400 shares | Ratio 0.54% | ▲0.13% | — |
| 2026-04-10 | MERRILL LYNCH INTERNATIONAL | Position 51,600 shares | Ratio 0.79% | ▼0.09% | — |
| 2026-03-31 | MERRILL LYNCH INTERNATIONAL | Position 57,400 shares | Ratio 0.88% | ▼0.03% | — |
| 2026-03-24 | Morgan Stanley MUFG Securities Co., Ltd. | Position 51,500 shares | Ratio 0.79% | ▼0.06% | — |
| 2026-03-19 | Morgan Stanley MUFG Securities Co., Ltd. | Position 55,700 shares | Ratio 0.85% | ▼0.10% | — |
| 2026-03-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 62,100 shares | Ratio 0.95% | ▼0.13% | — |
| 2026-03-13 | Morgan Stanley MUFG Securities Co., Ltd. | Position 70,300 shares | Ratio 1.08% | ▼0.02% | — |
| 2026-03-12 | Morgan Stanley MUFG Securities Co., Ltd. | Position 71,500 shares | Ratio 1.10% | ▼0.18% | — |
| 2026-03-09 | MERRILL LYNCH INTERNATIONAL | Position 59,200 shares | Ratio 0.91% | ▲0.01% | — |
| 2026-03-09 | Morgan Stanley MUFG Securities Co., Ltd. | Position 83,300 shares | Ratio 1.28% | ▼0.11% | — |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| GNI Group Ltd.2160 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kyowa Kirin Co.,Ltd.4151 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Takeda Pharmaceutical Company Limited4502 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Core30 |
| Astellas Pharma Inc.4503 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Large70 |
| Sumitomo Pharma Co.,Ltd.4506 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |